Impact of Smoking in Response to Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis : Methodologic Considerations for Longitudinal Observational Studies
Citation
Zhao , S , Yoshida , K , Jones , G T , Hughes , D M , Tedeschi , S K , Lyu , H , Moots , R J , Solomon , D H & Goodson , N J 2020 , ' Impact of Smoking in Response to Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis : Methodologic Considerations for Longitudinal Observational Studies ' , Arthritis Care & Research , vol. 72 , no. 4 , pp. 591-599 . https://doi.org/10.1002/acr.23851
Rights
This is the peer reviewed version of the following article: Zhao, S.S., Yoshida, K., Jones, G.T., Hughes, D.M., Tedeschi, S.K., Lyu, H., Moots, R.J., Solomon, D.H. and Goodson, N.J. (2020), Impact of Smoking in Response to Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis: Methodologic Considerations for Longitudinal Observational Studies. Arthritis Care Res, 72: 591-599., which has been published in final form at https://doi.org/10.1002/acr.23851. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.